patent/MA-39836-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-39836-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_992627e5907d88abd8d8b38563dab4d4
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2015-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_681ccb70007ad46d9dd47b0f213786b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa18f510e4e7d855d1d06e0db3cf32a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ec59534b1db090a7c967d51c44d091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3599eee3c5887ee2d2ed15cfdf1d8124
publicationDate	2017-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MA-39836-A
titleOfInvention	COMBINATION OF LENALIDOMIDE AND A POLYPEPTIDE CONSTRUCTION, AND ITS USES
abstract	The present invention relates to methods for the treatment of cancer, comprising administering to a cancer patient a construct of an attenuated anti-human ifn alpha-2b anti-cd38 antibody and lenalidomide or pomalidomide. Tumors which can be treated by these methods are tumors which include tumor cells expressing cd-38, including b cell lymphoma, multiple myeloma, non-Hodgkin lymphoma, chronic myelogenous leukemia, chronic lymphocytic leukemia and chronic lymphocytic leukemia. acute lymphoid leukemia.
priorityDate	2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134780 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504344 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498890

Total number of triples: 42.